LIA
LGND icon

LS Investment Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

LS Investment Advisors’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,065
Closed -$214K – 1141
2020
Q2 		$214K Sell
3,065
-130
-4% -$8.24K 0.01% 698
2020
Q1 		$145K Hold
3,195
– – 0.01% 756
2019
Q4 		$208K Buy
3,195
+938
+42% +$62.7K 0.01% 787
2019
Q3 		$140K Sell
2,257
-16
-0.7% -$1K 0.01% 937
2019
Q2 		$162K Sell
2,273
-258
-10% -$19K 0.01% 881
2019
Q1 		$198K Sell
2,531
-43
-2% -$3.26K 0.01% 803
2018
Q4 		$218K Buy
2,574
+381
+17% +$40.6K 0.02% 710
2018
Q3 		$376K Sell
2,193
-280
-11% -$42.2K 0.02% 600
2018
Q2 		$320K Sell
2,473
-20
-0.8% -$2.23K 0.02% 672
2018
Q1 		$257K Sell
2,493
-14
-0.6% -$1.39K 0.02% 743
2017
Q4 		$214K Buy
2,507
+183
+8% +$15.9K 0.01% 854
2017
Q3 		$197K Buy
2,324
+405
+21% +$32.1K 0.01% 929
2017
Q2 		$145K Hold
1,919
– – 0.01% 1008
2017
Q1 		$127K Buy
1,919
+579
+43% +$38.1K 0.01% 1041
2016
Q4 		$85K Buy
1,340
+62
+5% +$3.91K 0.01% 1096
2016
Q3 		$81K Hold
1,278
– – 0.01% 1071
2016
Q2 		$95K Buy
1,278
+121
+10% +$8.98K 0.01% 1014
2016
Q1 		$77K Buy
1,157
+67
+6% +$4.07K 0.01% 978
2015
Q4 		$74K Hold
1,090
– – 0.01% 985
2015
Q3 		$58K Hold
1,090
– – ﹤0.01% 1073
2015
Q2 		$69K Buy
+1,090
New +$59.5K 0.01% 1040

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

LS Investment Advisors's LGND Position: Q3 2020 in Review

LS Investment Advisors sold out of Ligand Pharmaceuticals (LGND) in Q3 2020, closing a stake of 3,065 shares — an estimated $214K sold.

LS Investment Advisors first reported a position in LGND in Q2 2015 and held it in 21 quarters. The position peaked at $376K in Q3 2018. 252 funds tracked by Wall St. Rank hold LGND as of Q3 2020.

  • LS Investment Advisors reported no remaining Ligand Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • LS Investment Advisors sold 3,065 Ligand Pharmaceuticals shares in Q3 2020, an estimated $214K.
  • LS Investment Advisors first reported a position in Ligand Pharmaceuticals in Q2 2015 and held it in 21 quarters.
  • LS Investment Advisors's Ligand Pharmaceuticals position peaked at $376K in Q3 2018.
  • 252 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.